Clinical, service, and cost outcomes of drug coverage edits and quantity limits
- PMID: 14613458
- PMCID: PMC10437240
- DOI: 10.18553/jmcp.2003.9.4.368
Clinical, service, and cost outcomes of drug coverage edits and quantity limits
Comment on
-
Evaluation of a monthly coverage maximum (drug-specific quantity limit) on the 5-HT1 agonists (triptans) and dihydroergotamine nasal spray.J Manag Care Pharm. 2003 Jul-Aug;9(4):335-45. doi: 10.18553/jmcp.2003.9.4.335. J Manag Care Pharm. 2003. PMID: 14613452 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical